Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
申请人:Bennani Youssef L.
公开号:US20090069365A1
公开(公告)日:2009-03-12
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
本发明通常涉及一系列化合物,药物组合物,以及将这些化合物和组合物作为治疗剂的用途。更具体地,本发明的化合物是六氢唑吲哌和八氢唑吲哌化合物。这些化合物是血清素受体(5-HT)配体,可用于治疗需要调节血清素受体(5-HT)活性的疾病,疾病和病症(例如焦虑,抑郁和肥胖症)。